1 |
식품의약품안전청, 미국 Dietary supplement의 안전성 평가 체계, Available from: http://www.foodnara.go.kr/hfoodi/ industry/(2007).
|
2 |
식품의약품안전청, 건강기능식품 기능성원료 및 기준규격 인정에 관한 규정 (식품의약품안전청 고시 제2011-34호).
|
3 |
식품의약품안전청, 건강기능식품의 기준 및 규격 (식품의 약품안전청 고시 제2011-68호).
|
4 |
식품의약품안전청, 건강기능식품 안전성평가 해설서 (사례 중심), Available from: http://www.foodnara.go.kr/hfoodi/industry/ (2008).
|
5 |
식품의약품안전청, 건강기능식품공전 해설서, Available from: http://www.foodnara.go.kr/hfoodi/industry/ (2008).
|
6 |
질병관리본부, 2008 국민건강통계 국민건강영양조사 제4기 2차년도, (2009).
|
7 |
식품의약품안전청, 건강기능식품 부작용 안전관리 연구 (09081영기안093), (2009).
|
8 |
식품의약품안전청, 건강기능식품 원료정보, Available from: http://www.foodnara.go.kr/hfoodi/industry/ (2012).
|
9 |
식품의약품안전청, 건강기능식품 기능성 표시.광고 가이드라인, Available from: http://www.foodnara.go.kr/hfoodi/industry/ (2008).
|
10 |
Food and Drug Administration. Warning on Hydroxycut products. Available from: http://www.fda.gov/ForConsumers/Consumer Updates/ucm152152.htm (2009).
|
11 |
Dara, L., Hewett, J., Lim, J., Hydroxycut hepatotoxicity: A case series and review of liver toxicity from herbal weight loss supplements, World Journal of Gastroenterology, 14, 6999-7004 (2008).
DOI
ScienceOn
|
12 |
Shim, M., Saab, S., Severe hepatotoxicity due to hydroxycut: A case report, Digestive Diseases and Sciences, 54, 406-408 (2009).
DOI
ScienceOn
|
13 |
Park. K., Kwon, O., The state of adverse event reporting and signal generation of dietary supplements in Korea, Regulatory Toxicology and Pharmacology, 57, 74-77 (2010).
DOI
ScienceOn
|
14 |
식품의약품안전청, 건강기능식품 부작용 추정 사례 수집 현황, Available from: http://www.foodnara.go.kr/hfoodi/ (2012).
|
15 |
Food and Drug Administration, The Dietary Supplement and Nonprescription Drug Consumer Protection Act (Public Law 109-462).
|
16 |
Frankos, V., Stree, D., O'Neill, R,, FDA regulation of dietary supplements and requirements regarding adverse event reporting, Clinical pharmacology & Therapeutics, 87, 239-244 (2010).
DOI
ScienceOn
|
17 |
보건복지부, 건강기능식품에 관한 법률 시행규칙 (보건복 지부령 제142호).
|